• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急诊科中磷苯妥英的不当使用。

Inappropriate fosphenytoin use in the ED.

作者信息

Johnson J, Wrenn K

机构信息

Department of Emergency Medicine, Vanderbilt University, Nashville, TN, USA.

出版信息

Am J Emerg Med. 2001 Jul;19(4):293-4. doi: 10.1053/ajem.2001.24471.

DOI:10.1053/ajem.2001.24471
PMID:11447516
Abstract

The objective of the study was to evaluate how often intravenous (IV) fosphenytoin is used when oral phenytoin loading is possible. The methods included a retrospective chart review of all patients receiving IV fosphenytoin in the emergency department. We prospectively derived criteria that identify patients with seizures who could receive oral phosphenytoin loading (awake on arrival, alert, no emesis, and lack of endotracheal intubation, repeated seizures, or status epilepticus after arrival). The setting of the study was at an urban, university hospital emergency department with an annual census of 55,000 patients. The outcomes included the number of patients receiving IV fosphenytoin who could have received oral phenytoin loading. From February 1997 to June 1999, 55 patients received IV fosphenytoin. Thirty of these patients (55%, 95% confidence interval 41%-68%) were felt to have received fosphenytoin appropriately. The remaining 25 (45%, 95% confidence interval 32%-59%) patients could have been loaded orally with phenytoin. In a single institution, fosphenytoin administration is inappropriate almost half the time. Oral phenytoin loading is less expensive and safe.

摘要

该研究的目的是评估在有可能进行口服苯妥英钠负荷给药的情况下,静脉注射(IV)磷苯妥英钠的使用频率。方法包括对急诊科所有接受静脉注射磷苯妥英钠的患者进行回顾性病历审查。我们前瞻性地制定了标准,以识别那些可以接受口服磷苯妥英钠负荷给药的癫痫患者(到达时清醒、警觉、无呕吐,且到达后无气管插管、反复癫痫发作或癫痫持续状态)。该研究在一家城市大学医院急诊科进行,年接诊量为55000名患者。结果包括那些本可以接受口服苯妥英钠负荷给药却接受了静脉注射磷苯妥英钠的患者数量。1997年2月至1999年6月,有55名患者接受了静脉注射磷苯妥英钠。其中30名患者(55%,95%置信区间41%-68%)被认为接受磷苯妥英钠治疗是恰当的。其余25名患者(45%,95%置信区间32%-59%)本可以口服苯妥英钠进行负荷给药。在单一机构中,几乎有一半的时间磷苯妥英钠的使用是不恰当的。口服苯妥英钠负荷给药成本更低且更安全。

相似文献

1
Inappropriate fosphenytoin use in the ED.急诊科中磷苯妥英的不当使用。
Am J Emerg Med. 2001 Jul;19(4):293-4. doi: 10.1053/ajem.2001.24471.
2
Evaluation of intramuscular fosphenytoin vs intravenous phenytoin loading in the ED.肌内注射苯妥英钠与静脉注射苯妥英钠在急诊科的负荷剂量比较。
Am J Emerg Med. 2011 Nov;29(9):983-8. doi: 10.1016/j.ajem.2010.05.005. Epub 2010 Aug 3.
3
Cost-effectiveness of oral phenytoin, intravenous phenytoin, and intravenous fosphenytoin in the emergency department.急诊科口服苯妥英钠、静脉注射苯妥英钠及静脉注射磷苯妥英钠的成本效益分析
Ann Emerg Med. 2004 Mar;43(3):386-97. doi: 10.1016/j.annemergmed.2003.10.011.
4
The safety, tolerability, and pharmacokinetics of fosphenytoin after intramuscular and intravenous administration in neurosurgery patients.磷苯妥英在神经外科患者中肌肉注射和静脉注射后的安全性、耐受性及药代动力学。
Pharmacotherapy. 1996 Jul-Aug;16(4):638-45.
5
Fosphenytoin farewell?磷苯妥英要告别了?
Ann Emerg Med. 2004 Mar;43(3):398-400. doi: 10.1016/j.annemergmed.2003.11.007.
6
Fosphenytoin: a novel phenytoin prodrug.磷苯妥英:一种新型苯妥英前体药物。
Pharmacotherapy. 1996 Sep-Oct;16(5):777-91.
7
Fosphenytoin.磷苯妥英
Expert Opin Drug Metab Toxicol. 2009 Jun;5(6):695-701. doi: 10.1517/17425250902997975.
8
A pharmacoeconomic evaluation of intravenous fosphenytoin (Cerebyx) versus intravenous phenytoin (Dilantin) in hospital emergency departments.医院急诊科中静脉注射磷苯妥英钠(赛瑞比克斯)与静脉注射苯妥英钠(大仑丁)的药物经济学评价
Clin Ther. 1996 Sep-Oct;18(5):953-66. doi: 10.1016/s0149-2918(96)80051-8.
9
Phenytoin and fosphenytoin: a model of cost and clinical outcomes.苯妥英钠和磷苯妥英钠:成本与临床结果模型
Pharmacotherapy. 1999 Jul;19(7):844-53. doi: 10.1592/phco.19.10.844.31556.
10
Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.磷苯妥英:癫痫急性治疗中的临床药代动力学及比较优势
Clin Pharmacokinet. 2003;42(1):33-58. doi: 10.2165/00003088-200342010-00002.

引用本文的文献

1
Development and Clinical Application of Phosphorus-Containing Drugs.含磷药物的研发与临床应用
Med Drug Discov. 2020 Dec;8:100063. doi: 10.1016/j.medidd.2020.100063. Epub 2020 Aug 25.